David Smith

David Smith

Presidente en THERACRYF PLC .

Fortuna: 2 M $ al 30/09/2026

60 años
Health Technology
Commercial Services
Consumer Services

Perfil

Dr. David A. Smith is a Non-Executive Chairman at TheraCryf Plc, an Independent Non-Executive Director at Thalia Therapeutics Plc and a Non-Executive Chairman at SPARTA Biodiscovery Ltd. He is on the Board of Directors at Thalia Therapeutics Plc and Nextmune Laboratories Ltd. Dr. Smith was previously employed as a Chief Executive Officer & Executive Director by Avacta Group Plc, a Chief Executive Officer & Director by Avacta Life Sciences Ltd., and a Director-Institute of Molecular Biophysics by University of Leeds.
He also served on the board at TheraGenetics Ltd. He received his undergraduate degree from The University of Manchester and a doctorate degree from The University of Manchester.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
04/06/2025 1.565.100 ( 0,33 % ) 1 M $ 30/09/2026
09/09/2026 36.212.888 ( 1,33 % ) 86 549 $ 30/09/2026

Cargos activos de David Smith

EmpresasCargoInicio
THALIA THERAPEUTICS PLC Director/Miembro de la Junta 08/01/2025
THERACRYF PLC Presidente 19/02/2025
Presidente -
Director/Miembro de la Junta 06/02/2009

Antiguos cargos conocidos de David Smith.

EmpresasCargoFin
AVACTA GROUP PLC Fundador 01/05/2024
Director Ejecutivo -
Director/Miembro de la Junta -
Corporate Officer/Principal -
Ver el detalle de la experiencia de David Smith.

Formación de David Smith.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

52

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Health Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology